Kaken Pharmaceutical (4521.TSE) Q4 2024 Earnings

8NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
42.24
145.28
248.32
351.37

Details

Expected EPS
N/A
Actual EPS
351.36655242462
Surprise EPS
351.37
Surprise Percent
+∞%

Description

Kaken Pharmaceutical (4521.TSE) has reported earnings of 351.36655242462 per share for Q4 2024.

0 Comments

Share your thoughts